Experts explore the complex interplay between cardiovascular and liver health, focusing on the challenges and opportunities in managing patients with cardiac-associated liver disease. Through a multidisciplinary lens, the session focuses on the impact of cardiovascular disease on end-stage liver disease; strategies for cardiovascular assessment in patients with advanced liver disease; and evidence-based approaches to optimize outcomes in this unique patient population. Speakers share insights to foster a collaborative framework for comprehensive patient care.
Explain the bidirectional relationship between cardiovascular disease and end-stage liver disease.
Review the impact of cardiovascular dysfunction on the progression and management of liver disease, including implications for liver transplantation.
Identify multidisciplinary strategies to address the challenges of managing cardiac-associated liver disease, particularly with respect to coordinated care models and best practices for cardiovascular assessment and risk stratification in patients with end-stage liver disease.
Discuss emerging research and clinical guidelines to optimize outcomes for patients with concurrent cardiac and liver conditions.